Tag: catheter ablation
Biosnese Webster’s Optrell mapping catheter launches in USA
Biosense Webster has today announced the US launch of the Optrell mapping catheter with Trueref technology powered by the Carto 3 system.
The Optrell mapping...
EHRA 2023: Novel score predicts heart failure following atrial fibrillation ablation
A score based on four readily available clinical and imaging parameters identifies the heart failure patients who benefit most from atrial fibrillation (AF) ablation, according...
Medtronic receives CE Mark approval for Affera mapping and ablation system...
Medtronic has announced today that it has received CE Mark for the Affera mapping and ablation system, which includes the Sphere-9 catheter and the...
Inpatient AF ablation associated with early mortality and post-procedure complications, study...
Atrial fibrillation (AF) ablation carried out in an inpatient setting is associated with higher rates of early mortality and subsequent complications when compared with...
Systematic review and meta-analysis finds P-wave duration to increase risk of...
In their updated meta-analysis of 4,175 patients, Stergios Intzes together with a team from the Democritus University of Thrace, Alexandroupoli, Greece and the Heart...
Medtronic completes enrolment in pulsed field ablation catheter trial for patients...
Medtronic has announced enrolment completion and final treatment in the SPHERE Per-AF, a US Food and Drug Administration (FDA) Investigational Device Exemption (IDE) trial....
Ablation as first-line treatment cuts AF progression compared to antiarrhythmic drugs
Ablation as a first-line treatment for atrial fibrillation (AF) disease is associated with significantly better clinical outcomes than starting with antiarrhythmic drugs.
These were the...
Same-day discharge for catheter ablation of atrial fibrillation deemed safe and...
A recent systematic review and meta-analysis, published in the Journal of Interventional Cardiac Electrophysiology, has deemed same-day discharge following catheter ablation of atrial fibrillation...
Hot balloon ablation and cryoballoon ablation deemed effective for AF treatment
Both cryoballoon ablation (CBA) and hot balloon ablation (HBA) are effective treatment options for atrial fibrillation (AF), however, patients treated with HBA are more...
Q-FFICIENCY trial shows promise for temperature-controlled ablation
Use of temperature-controlled ablation for the treatment of atrial fibrillation (AF) is effective and highly efficient, according to Jose Osorio—the director of electrophysiology at...
AtriAN Medical present results of Neural AF trial at AF Symposium...
According to a press release, AtriAN Medicals clinical data from the Neural atrial fibrillation (AF) study was presented by Vivek Reddy (Mount Sinai Hospital,...
Virtual ACC: Ethanol infusion in vein of Marshall improves catheter ablation outcomes
The infusion of ethanol via the vein of Marshall (VOM), coupled with catheter ablation, leads to improved outcomes for patients with persistent atrial ablation, according to the findings of a study presented by...
Tackling focal VT may improve catheter ablation in structural heart disease
Uncovering and abolishing focal ventricular tachycardia (VT) may further improve outcomes of catheter ablation in the treatment of structural heart disease, a study published...
CardioFocus treats first patients with HeartLight endoscopic ablation system in France
CardioFocus has announced that the first patients in France have been treated in the University Public Hospital of Nancy with the HeartLight endoscopic ablation...
Almost one in 200 patients die early after AF ablation in...
Early mortality following atrial fibrillation (AF) ablation affects nearly one in 200 patients, with the majority of deaths occurring during 30-day readmission, an analysis...
ESC 2019: Catheter ablation may be up to 10 times more...
Results from the Atrial fibrillation progression trial (ATTEST) were presented on 31 August at the European Society of Cardiology (ESC) Congress 2019 in Paris,...
ESC 2019: Guidelines on supraventricular tachycardias underline pivotal role of catheter...
The European Society of Cardiology (ESC) unveiled guidelines for treatment of supraventricular tachycardia (SVT) on the opening day of its Congress (ESC 2019; 31...
Eliminate AF shows low thromboembolic and bleeding events with edoxaban
Uninterrupted anticoagulation with edoxaban (Lixiana, Daiichi Sankyo) resulted in low rates of thromboembolic and bleeding events in patients with atrial fibrillation undergoing catheter ablation,...
CABANA finds reduced AF and better quality of life after ablation...
Catheter ablation for atrial fibrillation leads to a reduction in atrial fibrillation, better quality of life and lower hospitalisations than medical therapy, but does...
Clinical trial data further demonstrate safety and effectiveness of RHYTHMIA mapping...
Data from the TRUE-HD study has been announced during a late-breaking clinical trial session at the annual congress of the European Heart Rhythm Association...
Imricor announces new developments in MR compatible ablation products
Imricor is developing a magnetic resonance (MR) compatible injection catheter and has announced a joint development agreement with MiRTLE Medical to integrate MiRTLE’s MR...
Measuring outcomes after catheter ablations for AF
Published in the Journal of the American College of Cardiology (JACC): Clinical Electrophysiology, Björkenheim et al’s study of patient- and physician-reported outcomes of atrial...
Real-time cardiac mapping technology cleared by FDA
Acutus Medical has announced that the US Food and Drug Administration (FDA) cleared the AcQMap high resolution imaging and mapping system as well as...
Catheter ablation lowers mortality in atrial fibrillation patients with heart failure
Catheter ablation of atrial fibrillation significantly reduces mortality and hospitalisation in atrial fibrillation patients with heart failure in comparison with conventional treatment, data from...